IGM Biosciences Stock (NASDAQ: IGMS) stock price, news, charts, stock research, profile.
Open | $6.59 |
Close | $6.87 |
Volume / Avg. | 1.14M / 315.06K |
Day Range | 6.53 - 6.92 |
52 Wk Range | 3.81 - 17.70 |
Market Cap | $405.49M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 35.03% |
Days to Cover | 14.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IGM Biosciences (NASDAQ:IGMS) through any online brokerage.
Other companies in IGM Biosciences’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Altimmune (NASDAQ:ALT) and Fate Therapeutics (NASDAQ:FATE).
There is no analysis for IGM Biosciences.
IGM Biosciences has a consensus price target of $29.23.
The stock price for IGM Biosciences (NASDAQ: IGMS) is $6.87 last updated June 28, 2024 at 4:19 PM EDT.
There are no upcoming dividends for IGM Biosciences.
IGM Biosciences’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for IGM Biosciences.
IGM Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.